2 Oct 2026, 08:57
Presentations—
PYCPYC THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
11 Sept 2026, 08:25
Company Update—
4 Sept 2026, 17:10
OtherMS
4 Sept 2026, 08:30
Presentations—
3 Sept 2026, 08:21
Company Update—
2 Sept 2026, 15:52
Substantial Holders—
31 Aug 2026, 08:10
Presentations—
28 Aug 2026, 19:14
Company Administration—
28 Aug 2026, 19:12
Company Administration—
28 Aug 2026, 19:11
Financial Results—
28 Aug 2026, 19:08
Financial ResultsMS
26 Aug 2026, 16:54
Securities Administration—
18 Aug 2026, 08:16
Presentations—
14 Aug 2026, 11:02
Director Interests—
13 Aug 2026, 14:42
Securities Administration—
29 July 2026, 08:45
Quarterly ReportsMS
22 July 2026, 08:20
Company UpdateMS
21 July 2026, 08:32
Company UpdateMS
20 July 2026, 19:03
Securities Administration—
20 July 2026, 08:28
Presentations—
15 July 2026, 18:12
Meetings & Governance—
8 July 2026, 09:01
Company Update—
7 July 2026, 08:21
Company Administration—
18 June 2026, 08:26
Securities Administration—
16 June 2026, 16:29
Substantial Holders—
15 June 2026, 15:01
Company Administration—
12 June 2026, 15:55
Meetings & Governance—
26 May 2026, 19:23
Company Administration—
22 May 2026, 09:17
Presentations—
18 May 2026, 19:06
Substantial Holders—
12 May 2026, 09:07
Presentations—
11 May 2026, 18:56
Securities Administration—
7 May 2026, 09:03
Company UpdateMS
4 May 2026, 09:14
PresentationsMS
28 Apr 2026, 18:44
Securities Administration—
28 Apr 2026, 18:34
Securities Administration—
28 Apr 2026, 09:12
Quarterly ReportsMS
27 Apr 2026, 09:48
Company Update—
15 Apr 2026, 10:53
Company UpdateMS
1 Apr 2026, 20:25
Substantial Holders—
27 Mar 2026, 13:17
Director Interests—
27 Mar 2026, 09:58
Company Update—
24 Mar 2026, 09:01
Company Update—
16 Mar 2026, 09:19
Company Update—
10 Mar 2026, 18:41
Director Interests—
9 Mar 2026, 19:55
Securities Administration—
6 Mar 2026, 09:46
Securities Administration—
4 Mar 2026, 19:11
Company Administration—
4 Mar 2026, 09:29
Capital RaisingMS
27 Feb 2026, 08:04
Company UpdateMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 2 Oct 2026, 08:57 | RP11 PROGRAM - PRESENTATION AT EURETINA 2026 | Presentations | — | 03026 | |
| 11 Sept 2026, 08:25 | PKD - First Patient Dosed in OLE Study | Company Update | — | 11001 | |
| 4 Sept 2026, 17:10 | S&P DJI Announces September 2026 Quarterly Rebalance | Other | MS | — | |
| 4 Sept 2026, 08:30 | Investor Webinar Presentation Q3 2026 | Presentations | — | 03026 | |
| 3 Sept 2026, 08:21 | ADOA Program - Data Presentation | Company Update | — | 03026, 11001 | |
| 2 Sept 2026, 15:52 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 31 Aug 2026, 08:10 | PKD - Presentation of Clinical Safety Data | Presentations | — | 03026 | |
| 28 Aug 2026, 19:14 | 2026 Corporate Governance Statement | Company Administration | — | 03024 | |
| 28 Aug 2026, 19:12 | Appendix 4G | Company Administration | — | 03025 | |
| 28 Aug 2026, 19:11 | 2026 Annual Report to Shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 28 Aug 2026, 19:08 | Appendix 4E | Financial Results | MS | 03003 | |
| 26 Aug 2026, 16:54 | Notification regarding unquoted securities - PYC | Securities Administration | — | 06021 | |
| 18 Aug 2026, 08:16 | Investor Webinar | Presentations | — | 14014 | |
| 14 Aug 2026, 11:02 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 13 Aug 2026, 14:42 | Notification regarding unquoted securities - PYC | Securities Administration | — | 06021 | |
| 29 July 2026, 08:45 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 22 July 2026, 08:20 | PKD - Safety Committee Approves Dose Escalation | Company Update | MS | 11001 | |
| 21 July 2026, 08:32 | ADOA Program Update | Company Update | MS | 11001 | |
| 20 July 2026, 19:03 | Notification of cessation of securities - PYC | Securities Administration | — | 06027 | |
| 20 July 2026, 08:28 | Presentation At 2026 PMS Foundation Family Conference | Presentations | — | 03026 | |
| 15 July 2026, 18:12 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 8 July 2026, 09:01 | Grant of Patents by the US Patent Office | Company Update | — | 11001 | |
| 7 July 2026, 08:21 | Appointment of Chief Financial Officer | Company Administration | — | 12008 | |
| 18 June 2026, 08:26 | Notification of cessation of securities - PYC | Securities Administration | — | 06027 | |
| 16 June 2026, 16:29 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 15 June 2026, 15:01 | Company Secretary Appointment/Resignation | Company Administration | — | 12007 | |
| 12 June 2026, 15:55 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007, 16002 | |
| 26 May 2026, 19:23 | Change to CEO remuneration | Company Administration | — | 12008 | |
| 22 May 2026, 09:17 | 2026 Q2 Investor Webinar Presentation | Presentations | — | 03026 | |
| 18 May 2026, 19:06 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 12 May 2026, 09:07 | Investor Webinar | Presentations | — | 14014 | |
| 11 May 2026, 18:56 | Notification of cessation of securities - PYC | Securities Administration | — | 06027 | |
| 7 May 2026, 09:03 | PKD - Initiation of Multiple Dose Clinical Trial | Company Update | MS | 11001 | |
| 4 May 2026, 09:14 | Presentation of Ophthalmology Clinical Trial Data at ARVO | Presentations | MS | 03026 | |
| 28 Apr 2026, 18:44 | Exercise of Options and Cleansing Notice | Securities Administration | — | 06009, 06018 | |
| 28 Apr 2026, 18:34 | Application for quotation of securities - PYC | Securities Administration | — | 06020 | |
| 28 Apr 2026, 09:12 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 27 Apr 2026, 09:48 | Orphan Drug Designation Granted for RP11 by EMA | Company Update | — | 11001 | |
| 15 Apr 2026, 10:53 | ADOA Program - SRC Approve Progression to Multi-Dose Study | Company Update | MS | 11001 | |
| 1 Apr 2026, 20:25 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 27 Mar 2026, 13:17 | Change of Director's Interest Notice RH | Director Interests | — | 02009 | |
| 27 Mar 2026, 09:58 | PKD - Presentation at World Congress of Nephrology | Company Update | — | 03026, 11001 | |
| 24 Mar 2026, 09:01 | ADOA Program - Presentation at NANOS 2026 | Company Update | — | 03026, 11001 | |
| 16 Mar 2026, 09:19 | Regulatory Alignment on Registrational Trial Requirements | Company Update | — | 11001 | |
| 10 Mar 2026, 18:41 | Change of Director's Interest Notice RH IC | Director Interests | — | 02009 | |
| 9 Mar 2026, 19:55 | Application for quotation of securities - PYC | Securities Administration | — | 06020 | |
| 6 Mar 2026, 09:46 | Application for quotation of securities - PYC | Securities Administration | — | 06020 | |
| 4 Mar 2026, 19:11 | Joint Company Secretary Appointment | Company Administration | — | 12007 | |
| 4 Mar 2026, 09:29 | Completion of Retail Entitlement Offer | Capital Raising | MS | 06008 | |
| 27 Feb 2026, 08:04 | PKD Clinical Trial - Approval to Escalate Dosing | Company Update | MS | 11001 |
1–50 of 107
1 / 3